danazol has been researched along with Leukemia, Promyelocytic, Acute in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haase, D; Hehlmann, R; Hild, F; Lengfelder, E; Simon, M | 1 |
Azuma, H; Kanagawa, Y; Mima, N; Miyamoto, K; Saito, S; Shigekiyo, T; Shirakawa, M; Watanabe, A; Yamaguchi, H | 1 |
2 other study(ies) available for danazol and Leukemia, Promyelocytic, Acute
Article | Year |
---|---|
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Topics: Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Danazol; Drug Evaluation; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Tamoxifen; Time Factors; Tretinoin | 1994 |
An in vitro system for identifying agents capable of changing serum lipoprotein(a) concentration by regulating the transcriptional activity of the apolipoprotein(a) gene promoter.
Topics: Adult; Apolipoproteins; Apoprotein(a); Base Sequence; Cell Line; Danazol; DNA; DNA Primers; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hepatoblastoma; Humans; Interleukin-6; Kinetics; Leukemia, Promyelocytic, Acute; Lipoprotein(a); Liver Neoplasms; Luciferases; Male; Middle Aged; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcription, Genetic; Transfection; Tretinoin; Triiodothyronine; Tumor Cells, Cultured; Vitamin E | 1996 |